IMPEDIMED LIMITED — Director's Dealing 2017

Aug 29, 2017

Appendix
3Y Change
of
Director’s
Interest
Notice

Rule
3.19A.2

**Appendix

3Y**

**Change

of
Director’s
Interest
Notice**

_Information
or
documents
not
available
now
must
be
given
to
ASX
as
soon
as
available.

Information
and documents
given
to
ASX
become
ASX’s
property
and
may
be
made
public._

Introduced
30/09/01
Amended
01/01/11

Name
of
entity:
ImpediMed
Limited

**ABN:

089
705
144**

We
(the
entity)
give
ASX
the
following
information
under
listing
rule
3.19A.2
and
as
agent for
the
director
for
the
purposes
of
section
205G
of
the
Corporations
Act.

Name of Director	Donald Williams
Date of last notice	21 March 2017

**Part

1
-­‐
Change
of
director’s
relevant
interests
in
securities**

In
the
case
of
a
trust,
this
includes
interests
in
the
trust
made
available
by
the
responsible
entity
of
the
trust

Note:
In
the
case
of
a
company,
interests
which
come
within
paragraph
(i)
of
the
definition
of
“notifiable interest
of
a
director”
should
be
disclosed
in
this
part.

interest of a director” should be disclosed in this part.
Direct or indirect interest	Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances
giving rise to the relevant interest.
Date of change	24 August 2017
No. of securities held prior to change	Nil
Class	Ordinary Shares
Number acquired	30,000
Number disposed	Nil
Value/Consideration	$0.61 per share
Note: If consideration is non-cash, provide
details and estimated valuation

• See
  chapter
  19
  for
  defined
  terms.

01/01/2011
Appendix
3Y
Page
1

Appendix
3Y Change
of
Director’s
Interest
Notice

No. of securities held after change	30,000 Fully paid ordinary shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	On market trade

**Part

2
–
Change
of
director’s
interests
in
contracts**

Note:
In
the
case
of
a
company,
interests
which
come
within
paragraph
(ii)
of
the
definition
of
“notifiable interest
of
a
director”
should
be
disclosed
in
this
part.

Detail of contract
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part
3
–[+] Closed
period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?

Date
of
Notice:
30
August
2017

• See
  chapter
  19
  for
  defined
  terms.

Appendix
3Y
Page
2

01/01/2011